Vimarsana
Biggest News Aggregation in the World

Page 2 - Induced Stem Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Induced Stem Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Induced Stem Cells Today - Breaking & Trending Today

In a First, Scientists Say They Created 'Embryo-Like' Structures From Monkey Stem Cells - Vimarsana News

In a First, Scientists Say They Created 'Embryo-Like' Structures From Monkey Stem Cells

Researchers in China implanted the structures in three surrogate monkeys, but they did not become viable fetuses.

Fujifilm Invests in PhenoVista Biosciences from its Life Sciences Corporate Venture Capital Fund - Vimarsana News

Fujifilm Invests in PhenoVista Biosciences from its Life Sciences Corporate Venture Capital Fund

TOKYO, December 14, 2022 – FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announces its investment in PhenoVista Biosciences (PhenoVista), a contract research organization (CRO) and leading provider of both custom and off-the-shelf imaging-based assay services based in San Diego, CA.

Stem Cell Agency Expands Industry Alliance Program to Accelerate Therapies - Vimarsana News

Stem Cell Agency Expands Industry Alliance Program to Accelerate Therapies

South San Francisco, CA – An ever-growing array of academic and industry resources are required to rapidly translate scientific discoveries and emerging technologies toward safe and effective regenerative medicine therapies for patients

Single-cell map of heart failure suggests possible therapeutic targets - Vimarsana News

Single-cell map of heart failure suggests possible therapeutic targets

Scientists from the Precision Cardiology Lab (PCL) of the Broad Institute of MIT and Harvard and Bayer have generated detailed maps of a variety of cell types in the heart that are involved in two major causes of heart failure: dilated and hypertrophic cardiomyopathy (DCM and HCM), which both impair the heart’s pumping ability. 

Sugar Land nonprofit approved for stem cell trial - Vimarsana News

Sugar Land nonprofit approved for stem cell trial

The Hope Biosciences Stem Cell Research Foundation (HBSCRF) in Sugar Land announced April 28 it had received authorization from the Food and Drug Administration (FDA) for a Phase II clinical